19-50977674-C-A
Variant names:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_005046.4(KLK7):c.624G>T(p.Pro208Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000969 in 1,613,300 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0053 ( 6 hom., cov: 32)
Exomes 𝑓: 0.00052 ( 7 hom. )
Consequence
KLK7
NM_005046.4 synonymous
NM_005046.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.28
Genes affected
KLK7 (HGNC:6368): (kallikrein related peptidase 7) This gene encodes a member of the kallikrein subfamily of serine proteases. These enzymes have diverse physiological functions and many kallikrein genes are biomarkers for cancer. The encoded protein has chymotrypsin-like activity and plays a role in the proteolysis of intercellular cohesive structures that precedes desquamation, the shedding of the outermost layer of the epidermis. The encoded protein may play a role in cancer invasion and metastasis, and increased expression of this gene is associated with unfavorable prognosis and progression of several types of cancer. Polymorphisms in this gene may play a role in the development of atopic dermatitis. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, which is one of fifteen kallikrein subfamily members located in a gene cluster on chromosome 19. [provided by RefSeq, May 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant 19-50977674-C-A is Benign according to our data. Variant chr19-50977674-C-A is described in ClinVar as [Benign]. Clinvar id is 781474.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.28 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00532 (811/152316) while in subpopulation AFR AF= 0.0185 (768/41568). AF 95% confidence interval is 0.0174. There are 6 homozygotes in gnomad4. There are 394 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 6 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KLK7 | NM_005046.4 | c.624G>T | p.Pro208Pro | synonymous_variant | Exon 6 of 6 | ENST00000595820.6 | NP_005037.1 | |
KLK7 | NM_139277.2 | c.624G>T | p.Pro208Pro | synonymous_variant | Exon 6 of 6 | NP_644806.1 | ||
KLK7 | NM_001243126.1 | c.603G>T | p.Pro201Pro | synonymous_variant | Exon 5 of 5 | NP_001230055.1 | ||
KLK7 | NM_001207053.2 | c.408G>T | p.Pro136Pro | synonymous_variant | Exon 5 of 5 | NP_001193982.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00532 AC: 809AN: 152198Hom.: 6 Cov.: 32
GnomAD3 genomes
AF:
AC:
809
AN:
152198
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00131 AC: 328AN: 251080Hom.: 3 AF XY: 0.000928 AC XY: 126AN XY: 135752
GnomAD3 exomes
AF:
AC:
328
AN:
251080
Hom.:
AF XY:
AC XY:
126
AN XY:
135752
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000515 AC: 753AN: 1460984Hom.: 7 Cov.: 32 AF XY: 0.000442 AC XY: 321AN XY: 726780
GnomAD4 exome
AF:
AC:
753
AN:
1460984
Hom.:
Cov.:
32
AF XY:
AC XY:
321
AN XY:
726780
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00532 AC: 811AN: 152316Hom.: 6 Cov.: 32 AF XY: 0.00529 AC XY: 394AN XY: 74476
GnomAD4 genome
AF:
AC:
811
AN:
152316
Hom.:
Cov.:
32
AF XY:
AC XY:
394
AN XY:
74476
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Aug 29, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at